These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23721519)

  • 1. Claudin 1 expression in basal-like breast cancer is related to patient age.
    Blanchard AA; Ma X; Dueck KJ; Penner C; Cooper SC; Mulhall D; Murphy LC; Leygue E; Myal Y
    BMC Cancer; 2013 May; 13():268. PubMed ID: 23721519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claudin expression in high-grade invasive ductal carcinoma of the breast: correlation with the molecular subtype.
    Lu S; Singh K; Mangray S; Tavares R; Noble L; Resnick MB; Yakirevich E
    Mod Pathol; 2013 Apr; 26(4):485-95. PubMed ID: 23222490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype.
    Blanchard AA; Skliris GP; Watson PH; Murphy LC; Penner C; Tomes L; Young TL; Leygue E; Myal Y
    Virchows Arch; 2009 Jun; 454(6):647-56. PubMed ID: 19387682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models.
    Dunlap SM; Chiao LJ; Nogueira L; Usary J; Perou CM; Varticovski L; Hursting SD
    Cancer Prev Res (Phila); 2012 Jul; 5(7):930-42. PubMed ID: 22588949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
    Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
    Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Claudin 1 Expression Levels Affect miRNA Dynamics in Human Basal-Like Breast Cancer Cells.
    Majer A; Blanchard AA; Medina S; Booth SA; Myal Y
    DNA Cell Biol; 2016 Jul; 35(7):328-39. PubMed ID: 26982264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudin-Low Breast Cancer; Clinical & Pathological Characteristics.
    Dias K; Dvorkin-Gheva A; Hallett RM; Wu Y; Hassell J; Pond GR; Levine M; Whelan T; Bane AL
    PLoS One; 2017; 12(1):e0168669. PubMed ID: 28045912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of basal cytokeratin expression in breast cancer.
    Alshareeda AT; Soria D; Garibaldi JM; Rakha E; Nolan C; Ellis IO; Green AR
    Breast Cancer Res Treat; 2013 May; 139(1):23-37. PubMed ID: 23588953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.
    Lanigan F; McKiernan E; Brennan DJ; Hegarty S; Millikan RC; McBryan J; Jirstrom K; Landberg G; Martin F; Duffy MJ; Gallagher WM
    Int J Cancer; 2009 May; 124(9):2088-97. PubMed ID: 19142967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
    Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
    Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of Forkhead Box c2 with subtypes and invasive ability of invasive breast cancer.
    Dai J; Wang JY; Yang LL; Xiao Y; Qu ZL; Qin SH; Ruan QR
    J Huazhong Univ Sci Technolog Med Sci; 2014 Dec; 34(6):896-901. PubMed ID: 25480587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratins 5 and 17 Maintain an Aggressive Epithelial State in Basal-Like Breast Cancer.
    McGinn O; Riley D; Finlay-Schultz J; Paul KV; Kabos P; Sartorius CA
    Mol Cancer Res; 2022 Sep; 20(9):1443-1455. PubMed ID: 35639459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
    Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
    Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16INK4a expression in basal-like breast carcinoma.
    Bohn OL; Fuertes-Camilo M; Navarro L; Saldivar J; Sanchez-Sosa S
    Int J Clin Exp Pathol; 2010 Jun; 3(6):600-7. PubMed ID: 20661408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High
    Onaga C; Tamori S; Motomura H; Ozaki A; Matsuda C; Matsuoka I; Fujita T; Nozaki Y; Hara Y; Kawano Y; Harada Y; Sato T; Mano Y; Sato K; Akimoto K
    Anticancer Res; 2021 Jan; 41(1):43-54. PubMed ID: 33419798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: significance in claudin-low breast cancer cells.
    Alsuliman A; Colak D; Al-Harazi O; Fitwi H; Tulbah A; Al-Tweigeri T; Al-Alwan M; Ghebeh H
    Mol Cancer; 2015 Aug; 14():149. PubMed ID: 26245467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Characteristics and Therapeutic Vulnerabilities of Claudin-low Breast Cancers Derived from Cell Line Models.
    Voutsadakis IA
    Cancer Genomics Proteomics; 2023; 20(6):539-555. PubMed ID: 37889067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
    Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
    Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer-insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system.
    Wafai R; Williams ED; de Souza E; Simpson PT; McCart Reed AE; Kutasovic JR; Waltham M; Snell CE; Blick T; Thompson EW; Hugo HJ
    Breast Cancer Res; 2020 Dec; 22(1):136. PubMed ID: 33276802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.
    Hollier BG; Tinnirello AA; Werden SJ; Evans KW; Taube JH; Sarkar TR; Sphyris N; Shariati M; Kumar SV; Battula VL; Herschkowitz JI; Guerra R; Chang JT; Miura N; Rosen JM; Mani SA
    Cancer Res; 2013 Mar; 73(6):1981-92. PubMed ID: 23378344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.